Continued genetic screening and analysis of Arabidopsis mutants has extended our view of brassinosteroid signaling beyond hormone perception to downstream events involving a negative cytoplasmic regulator and nuclear localized positive activators of the brassinosteroid response. 
Molecular genetic and biochemical analyses of BRI1 have revealed a functional receptor kinase with a leucine-rich repeat extracellular domain involved directly or indirectly in brassinosteroid binding, and an active cytoplasmic kinase domain that autophosphorylates on multiple serine and threonine residues [6] [7] [8] . Until very recently, however, no information was available on events downstream of the initial perception of brassinosteroids by BRI1. The inability to identify mutations in non-BRI1 genes by genetic screens for brassinosteroid insensitivity was thought to be due either to redundancy in downstream components or to lethality when loss-of-function mutations occurred in one or more of these elements. A closer examination of Arabidopsis dwarfs obtained in a genetic screen for brassinosteroid insensitivity revealed a new mutant, brassinosteroid-insensitive 2 (bin2), which in the homozygous state closely resembles the bri1 phenotype but which results from a lesion in a distinct genetic locus. Moreover, while bri1 alleles are all recessive loss-offunction mutations, bin2 is a semi-dominant gain-offunction mutant [9] .
BIN2 has now been cloned, and was found to encode a cytoplasmic serine/threonine kinase, the catalytic domain of which shares 70% sequence similarity with the Drosophila shaggy kinase and mammalian glycogen synthase kinase-3 (GSK-3) [10] . GSK-3/shaggylike kinases are found widely among eukaroytes and are often negative regulators of signal transduction pathways controlling metabolism and developmental events such as cell-fate determination and pattern formation [11] . In mammals, GSK-3 phos-phorylates and inactivates glycogen synthase: insulin initiates a cascade of events that results in the phosphorylation and inactivation of GSK-3 and the subsequent activation of glycogen synthase, which then converts glucose to glycogen. During early devel-opment of invertebrates and vertebrates, GSK-3/shaggy kinases negatively regulate the Wingless/Wnt signaling pathway by phosphorylating β-catenin, inducing its proteasomedependent degradation. When the proper developmental signal is perceived by a seven-pass transmembrane Frizzled family receptor, the GSK-3/shaggy kinase is inactivated resulting in accumulation of β-catenin, which moves to the nucleus where it participates in trans-activation of a set of genes essential for developmental pattern formation [11] .
In view of the roles GSK-3/shaggy kinases play as negative regulators of several eukaryotic signal transduction pathways, it is perhaps not surprising that BIN2 has been shown by biochemical and genetic analysis to be a negative regulator of brassinosteroid signal transduction. The appearance of a bri1-like phenotype in transgenic plants expressing BIN2 was found to correlate with the level of BIN2 transcripts, with the highest overexpression lines showing the most severe phenotype. Furthermore, recombinant BIN2 kinase carrying the bin2 mutation was more active in a peptide kinase assay than the wild-type recombinant protein [10] . Thus, bin2 appears to be a hypermorphic mutant A possible biological significance for this nuclear localization is suggested by the fact that several genes encoding wall-modifying enzymes involved in cell expansion are overexpressed in bes1-D mutants [12] . Furthermore, the extent of nuclear localization of BZR1 is correlated with the most actively expanding zones of dark-grown Arabidopsis hypocotyls [13] . While BES1 and BZR1 appear to have overlapping functions, they are not completely redundant, as bes1-D and bzr1-D mutant plants differ in their lightgrown phenotypes and in the extent of feedback inhibition of brassinosteroid biosynthesis.
The emerging picture of brassinosteroid signal transduction reveals a pathway that shares much of the logic of Wnt signaling in vertebrates and invertebrates (Figure 2) . After plasma membrane perception by brassinosteroids, an unknown number of steps leads to inactivation of the negative regulator BIN2, which allows the unphosphorylated form of BES1 (and BZR1?) to accumulate and translocate to the nucleus. These proteins then activate the expression of brassinosteroid response genes by an unknown mechanism. It should be noted that, thus far, only the BIN2 shaggylike kinase has been shown to have actual sequence homology to components of the Wnt pathway.
Lastly, GSK-3/shaggy kinases are known to have roles in other signaling pathways in many eukaryotes [14] and an independent genetic analysis of Arabidopsis ucu1 mutants -allelic to bin2 -suggests that the BIN2/UCU1 kinase may also be involved in 
